Author | James L. Gulley, MD, PhD | OncLive

Author | James L. Gulley, MD, PhD

Articles

Dr. Gulley on Checkpoint Inhibitors in Bladder Cancer

March 14, 2016

Video

James L. Gulley, MD, PhD, Chief, Genitourinary Malignancies Branch, Senior Investigator, Head, Immunotherapy Section, Director, Medical Oncology Service, CCR Office of the Clinical Director, National Cancer Institute, discusses checkpoint inhibitors in bladder cancer.

Dr. Gulley Discusses Vaccine Responses

September 10, 2013

Video

James L. Gulley, MD, PhD, Head, Clinical Trials Group, Deputy Laboratory Chief, National Cancer Institute, discusses measuring response to vaccines.

Dr. Gulley on the Adverse Event Profile for PROSTVAC

June 27, 2013

Video

James L. Gulley, MD, PhD, Head, Clinical Trials Group, Deputy Laboratory Chief, National Cancer Institute (NCI), gives an overview of the adverse event profile for PROSTVAC.

x